Browse drugs

…e generally agreed on the short-term dual antiplatelet therapy (DAPT) for mild stroke or transient ischaemic attack (TIA), there is …

…ibed duration of treatment. Eighty patients received short-term DAPT. There were no significant differences in the rate of thromboti…

… effectiveness and safety of early versus delayed initiation of DAPT in a cohort of patients with acute stroke treated with eCAS.Met…

…no obstructive culprit lesion, number-needed-to-test by CMR for DAPT deprescription was 3.Conclusions CMR in MINOCA is associated wi…

…seq, respectively. Bosentan (BST) and the γ-secretase inhibitor DAPT were tested for their effects in preventing angiogenesis defect…

…en. 30.2% (157/520) of cases were on dual antiplatelet therapy (DAPT) or therapeutic anticoagulation. Among the 520 Celt ACD closure…

…ative or non-coronary causes of troponin elevation, exposure to DAPT confers avoidable bleeding risk without clinical benefit. Local…

…Background Shorter dual antiplatelet therapy (DAPT) regimens may offer a more favourable risk-benefit profile comp…

…rgoing coronary stenting followed by dual antiplatelet therapy (DAPT), and scores range from 0 to 100.4 One group had a mean of 10.5…

…d prior to any antiplatelet loading. Dual antiplatelet therapy (DAPT) was initiated intravenously in all cases 6–12 hours post EVD. …

…cases. However, with adequate preparation, including the use of DAPT and IA tirofiban injections to prevent and manage thrombus form…